Researchers successfully transplanted myoblast cells into patients with scarred heart tissue, showing evidence of repair and regeneration. The procedure improved EF rates by 58% in just 12 weeks, offering a potential new hope for treating heart failure.
A study of 774 older men found that high hostility was associated with a higher risk of coronary heart disease, independent of other risk factors like high cholesterol. The study suggests that mental health interventions may be effective in reducing the risk of CHD for individuals with high hostility levels.
Harold A. Sorgenti receives the Petrochemical Heritage Award for his entrepreneurial and community leadership achievements in the petrochemical sector. The award recognizes his significant contributions to the modern sciences, industries, and economies.
A recent study at Duke University Medical Center found hospitals that adhere to established treatment guidelines for heart attacks have lower mortality rates. The researchers compared over 250,000 patients and found leading hospitals reported significantly better outcomes.
A new study by the American Heart Association found that death rates are significantly lower in hospitals that follow established guidelines for treating heart attacks. The study examined adherence to clinical practice guidelines at 1,085 US hospitals and found that leading hospitals had a 50% higher rate of beta-blocker use and a 30% ...
Researchers have successfully transmitted electrical signals in rat hearts using tissue-engineered cells, which may lead to a new treatment for heart block. The cells formed connections with cardiac cells and developed an electrical pathway within 10 weeks of implantation.
A recent study has provided the first direct evidence that transplanted muscle cells can form muscle fibers and blood vessels in damaged hearts. Satellite cells from patients' thigh muscles were injected into their heart tissue, surviving and differentiating into mature muscle fibers without triggering an immune reaction.
Researchers developed a new tissue-engineering technique using fibroblast and endothelial cells to create functional blood vessels. The engineered vessels demonstrated durability and resistance to blood clots in laboratory tests and short-term animal experiments.
Researchers successfully treated patients with scar tissue and impaired heart function after heart attacks by injecting their own bone marrow into the affected area. The treatment showed significant improvement in heart wall motion, persisting for at least 10 months in some patients.
Researchers found that emergency PCI is both safe and effective at hospitals without on-site surgical ability. Delaying treatment doubles the risk of patient mortality. Hospitals with diagnostic heart catheterization laboratories can save lives by performing immediate balloon angioplasty for acute heart attack patients.